NCT06141057View on ClinicalTrials.gov

A Study to Compare Two Dosing Regimens for a New Malaria Vaccine

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
MalariaMalaria,FalciparumProtozoan InfectionsParasitic DiseaseInfectionsVector Borne Diseases
Interventions
BIOLOGICAL

Matrix M with RH5.1

50 µg of Matrix-M adjuvant with RH5.1 at different doses on days 0 and 28.

Trial Locations (1)

S10 2JF

Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield

All Listed Sponsors
lead

University of Oxford

OTHER